Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

447405

	registered interest
	date	25/01/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Zika Virus
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps are being taken to ensure (a) pregnant women and (b) other people intending to visit South America and the Caribbean are aware of the risks posed by Zika virus.
	tabling member constituency	East Londonderry
	tabling member printed	Mr Gregory Campbell
	uin	23943
	answer	answer is ministerial correction date of answer 28/01/2016 answer text <p>Public Health England (PHE) and the National Travel Health Network and Centre (NaTHNaC) have been carefully monitoring the Zika virus outbreak in the Americas since it was first reported in Brazil during May 2015. When the Brazilian Ministry of Health announced a potential link between maternal Zika virus infection and microcephaly in December 2015, PHE and NaTHNaC published updated advice for travellers to South and Central America and the Caribbean, including specific advice for pregnant women. This advice continues to be updated regularly as more information becomes available.</p><br /><p>PHE has been and continues to liaise with the Royal College of Obstetricians and Gynaecologists, Association of British Neurologists and the Association of British Travel Agents who have published updates on their respective websites. The Foreign and Commonwealth Office has also updated its country travel advice pages with information about Zika virus.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 28/01/2016 16:01:12 answering member 3918 label Biography information for Jane Ellison
	tabling member	1409 label Biography information for Mr Gregory Campbell

447476

	registered interest
	date	25/01/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	UnitingCare Partnership
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government, further to the Written Answer by Lord Prior of Brampton on 19 January (HL4840), why the independent review of the contract between Cambridgeshire and Peterborough Clinical Commissioning Group and UnitingCare Partnership will only focus on the commissioner perspective.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL5378
	answer	answer is ministerial correction date of answer 08/02/2016 answer text <p>We are advised that NHS England’s review of the contract between Cambridgeshire and Peterborough Clinical Commissioning Group and UnitingCare Partnership will focus on the commissioner perspective. Monitor, as the sector regulator for health services in England, will also be conducting a review.</p><p>However, Monitor’s review will assess the contract from the perspective of the providers involved and consider how relevant issues might be mitigated in the future. Monitor and NHS England will share their respective findings with each other.</p> answering member printed Lord Prior of Brampton question first answered 08/02/2016 13:42:53 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

447393

	registered interest
	date	25/01/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Self-Harm: Children
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, pursuant to the Answer of 21 January 2016 to Question 22945, what steps he plans to take to tackle the increase in the number of people under 18 who have been admitted to hospital as a result of self-harm since 2010.
	tabling member constituency	Liverpool, Wavertree
	tabling member printed	Luciana Berger
	uin	24077
	answer	answer is ministerial correction date of answer 28/01/2016 answer text <p>The Government is committed to delivering the transformation of children and young people’s mental health as outlined in <em>Future in Mind. </em>Local Transformation Plans, which NHS England has now assured, and the £30 million that was released in December 2015 for clinical commissioning groups to deliver their improved local offer, which must cover the whole spectrum of services for children and young people’s mental health and wellbeing, including prevention, early intervention and access as well as support for those who self-harm.</p><br /><p>In the Autumn Statement 2014 increased funding of £150 million over the course of this Parliament was announced to improve eating disorder services for children and young people with mental health problems in England, and any capacity freed up through this investment is to be redeployed to improve services for both crisis and people who self-harm.</p><br /><p>In relation to the increase of young people who have been admitted to hospital as a result of self-harm it is important to note that revised guidance was issued by the Health and Social Care Information Centre to National Health Service trusts to clarify the use of reporting codes from 1 April 2013, which may account for some of the increase in figures from that point onwards.</p> answering member constituency North East Bedfordshire answering member printed Alistair Burt question first answered 28/01/2016 11:39:28 answering member 1201 label Biography information for Alistair Burt
	tabling member	4036 label Biography information for Luciana Berger

447402

	registered interest
	date	25/01/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Respiratory System: Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how much the National Institute for Health Research has invested in research into (a) lung cancer, (b) adult asthma, (c) pneumonia, (d) chronic obstructive pulmonary disease, (e) idiopathic pulmonary fibrosis, (f) mesothelioma and (g) childhood wheezing and childhood respiratory infection in each of the last five years.
	tabling member constituency	Coventry South
	tabling member printed	Mr Jim Cunningham
	uin	23925
	answer	answer is ministerial correction date of answer 28/01/2016 answer text <p>The information requested is not available. Spend on research funded directly by the Department’s National Institute for Health Research is categorised by Health Research Classification System (HRCS) health categories including ‘cancer’ and ‘respiratory’. There are no HRCS health sub-categories, such as for specific cancer sites or respiratory diseases.</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 28/01/2016 15:41:24 answering member 4020 label Biography information for George Freeman
	tabling member	308 label Biography information for Mr Jim Cunningham

447245

	registered interest
	date	25/01/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	National Clinical Directors
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many National Clinical Directors will be appointed; and what areas those National Clinical Directors will cover after April 2016.
	tabling member constituency	Scunthorpe
	tabling member printed	Nic Dakin
	uin	23872
	answer	answer is ministerial correction date of answer 01/02/2016 answer text <p>NHS England will be supported by 17 National Clinical Directors (NCDs) from 1 April 2016. 14 of these roles have been advertised and will be newly appointed. Three NCDs will continue in post into 2016/17; these are NCDs for Maternity and Women’s Health, Learning Disabilities and Innovation. The 17 roles are:</p><p> </p><p>National Clinical Director (Major Programmes):</p><p>— Cancer</p><p>— Mental Health</p><p>— Diabetes and Obesity</p><p>— Learning Disabilities</p><p>— Urgent and Emergency Care</p><p>— Maternity and Women’s Health</p><p>— Innovation</p><p> </p><p>National Clinical Director (Service Improvement):</p><p>― Cardiac Services</p><p>― Stroke</p><p>― Respiratory</p><p>― End of Life Care</p><p>― Diagnostics, including Imaging and Endoscopy</p><p>― Musculoskeletal</p><p>― Dementia</p><p>― Emergency Preparedness and Critical Care</p><p> </p><p>National Clinical Director (Population Groups):</p><p>— Children, Young People and Transition to Adulthood</p><p>— Older People and Integrated Person-Centred Care</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 01/02/2016 13:50:28 answering member 4020 label Biography information for George Freeman
	tabling member	4056 label Biography information for Nic Dakin

447403

	registered interest
	date	25/01/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	National Clinical Directors
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how the objectives for NHS England's National Clinical Directors post April 2016 will be agreed.
	tabling member constituency	Scunthorpe
	tabling member printed	Nic Dakin
	uin	23929
	answer	answer is ministerial correction date of answer 28/01/2016 answer text <p>From 1 April 2016, objectives for the National Clinical Directors will be set according to the priority areas and major programmes, as set out in the Mandate and planning guidance. They will relate, where appropriate, to established programmes of service improvement.</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 28/01/2016 15:43:48 answering member 4020 label Biography information for George Freeman
	tabling member	4056 label Biography information for Nic Dakin

447391

	registered interest
	date	25/01/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS: Staff
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps the Government has taken to increase the number of BAME (a) executive and (b) non-executive staff of (i) NHS trusts, (ii) clinical commissioning groups and (iii) related arms length bodies since 2012.
	tabling member constituency	Stretford and Urmston
	tabling member printed	Kate Green
	uin	24037
	answer	answer is ministerial correction date of answer 02/02/2016 answer text <p>In 2014, NHS England, in partnership with the National Health Service and arm’s length bodies, developed a Workforce Race Equality Standard which requires NHS organisations to demonstrate progress against a number of indicators of workforce race equality, including a specific indicator to address the low levels of Black and Minority Ethnic representation at Board level.</p><p> </p><p>Since April 2015, the Standard has been included in the NHS contract for providers, and it will feature in the new assessment framework for clinical commissioning groups for 2016/17. The Standard has also been included in the Care Quality Commission’s inspections of provider organisations.</p><p> </p><p>In addition to supporting the implementation of the Standard, the arm’s length bodies are also applying it to their own workforces. Further information on the NHS Workforce Race Equality Standard can be found at:</p><p> </p><p><a href="https://www.england.nhs.uk/about/gov/equality-hub/equality-standard/" target="_blank">https://www.england.nhs.uk/about/gov/equality-hub/equality-standard/</a></p><p> </p><p>The Department keeps diversity in focus throughout the appointments process for non-executives of arm’s length bodies. The Department’s “Non-Executive Appointments Diversity Action Plan” is published annually which outlines progress and actions to improve the diversity of public appointments and can be found at:</p><p> </p><p><a href="https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/445660/Diversity_Action_Plan_14_15.pdf" target="_blank">https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/445660/Diversity_Action_Plan_14_15.pdf</a></p><p> </p><p>Cabinet Office publishes annual diversity statistics on new public appointments made by United Kingdom Ministers at:</p><p> </p><p><a href="https://www.gov.uk/government/publications/diversity-in-public-appointments#history" target="_blank">https://www.gov.uk/government/publications/diversity-in-public-appointments#history</a></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 02/02/2016 14:39:09 answering member 3918 label Biography information for Jane Ellison
	tabling member	4120 label Biography information for Kate Green

447396

	registered interest
	date	25/01/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what assessment his Department has made of the potential effect of the Access to Medical Treatments (Innovation) Bill on reducing the length of time it takes to bring a new drug to market.
	tabling member constituency	Ellesmere Port and Neston
	tabling member printed	Justin Madders
	uin	23994
	answer	answer is ministerial correction date of answer 28/01/2016 answer text <p>The purpose of the Access to Medical Treatments (Innovation) Bill is to promote access to innovative medical treatments. It is not specifically designed to reduce the length of time it takes to bring a new drug to market. To which end work is being done in parallel, notably through the Accelerated Access Review, which explores options to speed up access to innovative drugs, devices and diagnostics for National Health Service patients. Sir Hugh Taylor, the independent chair of the review will make his recommendations in the spring.</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 28/01/2016 16:12:14 answering member 4020 label Biography information for George Freeman
	tabling member	4418 label Biography information for Justin Madders

447406

	registered interest
	date	25/01/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what plans his Department has to hold NHS bodies accountable to the recommendations of the Accelerated Access Review.
	tabling member constituency	Scunthorpe
	tabling member printed	Nic Dakin
	uin	23928
	answer	answer is ministerial correction date of answer 28/01/2016 answer text <p>The Accelerated Access Review, which was set up to look at speeding up access to innovative drugs including those for rare diseases, devices and diagnostics for National Health Service patients, has been making strong progress since it was first announced in November 2014.</p><p><br> The review is independently chaired by Sir Hugh Taylor and has been engaging stakeholders extensively since the summer to gather evidence on the big questions the review is considering, and has developed a number of emerging solutions.</p><p><br> Sir Hugh published his interim report of the review on 27 October 2015. The report is high-level, direction-setting and grounded in evidence gathered through the review’s stakeholder engagement to date. Included in the report were proposals for a National Innovation Partnership of key bodies in the innovation pathway who would be party to a Concordat committing them to the ambitions set out in the review. The review has used a second phase of engagement to work closely with industry stakeholders, Government, the NHS and arm’s length bodies on these and other proposals set out in the interim report.</p><p><br> In April 2016 the review will conclude with Sir Hugh making his final recommendations to Government. The Department will review these recommendations and consider how best to respond.</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 28/01/2016 15:39:38 answering member 4020 label Biography information for George Freeman
	tabling member	4056 label Biography information for Nic Dakin

447508

	registered interest
	date	25/01/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS England
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government whether they have any plans to review the powers of the Chief Executive of NHS England in terms of making public policy statements.
	tabling member printed	Lord Scriven
	uin	HL5410
	answer	answer is ministerial correction date of answer 29/01/2016 answer text <p>NHS England is an independent body established by the Health and Social Care Act 2012. Its Chief Executive, Simon Stevens, can make public policy statements. There are no plans to review this.</p> answering member printed Lord Prior of Brampton question first answered 29/01/2016 11:59:40 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	4333 label Biography information for Lord Scriven